Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
BridgeBio Oncology Therapeutics Inc.
Market Cap
$280.37M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
N/A
Market Cap
$281.54M
Operating Margin
0.00%
TTM Avg
-13.69%
3Y Avg
-1436.87%
5Y Avg
-1163.68%
Market Cap
$282.64M
Operating Margin
-109.34%
TTM Avg
-104.90%
3Y Avg
-100.12%
5Y Avg
-81.51%
Market Cap
$284.31M
Operating Margin
-14.55%
TTM Avg
-6.56%
3Y Avg
-30.72%
5Y Avg
-57.13%
Market Cap
$285.42M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-384.25%
5Y Avg
-256.17%
Market Cap
$285.55M
Operating Margin
-1536.91%
TTM Avg
-768.46%
3Y Avg
-1621.10%
5Y Avg
-1715.52%
Market Cap
$288.79M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$271.81M
Operating Margin
-69.95%
TTM Avg
-45.20%
3Y Avg
-23.79%
5Y Avg
-11.42%
Market Cap
$270.80M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BridgeBio Oncology Therapeutics Inc. (BBOT) | $280.37M | 0.00% | 0.00% | 0.00% | N/A |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $281.54M | 0.00% | -13.69% | -1436.87% | -1163.68% |
| Standard BioTools Inc. (LAB)vs › | $282.64M | -109.34% | -104.90% | -100.12% | -81.51% |
| Aurora Cannabis Inc. (ACB)vs › | $284.31M | -14.55% | -6.56% | -30.72% | -57.13% |
| Sagimet Biosciences Inc. (SGMT)vs › | $285.42M | 0.00% | 0.00% | -384.25% | -256.17% |
| Abeona Therapeutics Inc. (ABEO)vs › | $285.55M | -1536.91% | -768.46% | -1621.10% | -1715.52% |
| Larimar Therapeutics, Inc. (LRMR)vs › | $288.79M | 0.00% | 0.00% | 0.00% | 0.00% |
| Vanda Pharmaceuticals Inc. (VNDA)vs › | $271.81M | -69.95% | -45.20% | -23.79% | -11.42% |
| Rocket Pharmaceuticals, Inc. (RCKT)vs › | $270.80M | 0.00% | 0.00% | 0.00% | 0.00% |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $292.59M | -144.71% | -144.71% | -144.71% | -144.71% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2022-12-31 | 0.00% |
